U.S. authorities subpoena GSK regarding diabetes drug Avandia

10/21/2010 | Wall Street Journal, The

GlaxoSmithKline has received a subpoena from the Justice Department and "civil investigative demands" from state authorities concerning the development and marketing of diabetes treatment Avandia. "These inquiries are at an early stage, and GSK is cooperating with these offices," the drugmaker said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY